Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
The effect of host immune status on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains unknown. Here, we report the first case of coronavirus disease 2019 (COVID-19) with human immunodeficiency virus type 1 (HIV-1)/hepatitis C virus coinfection, who showed a persistently negative SARS-CoV-2 RNA test but delayed antibody response in the plasma. This case highlights the influence of HIV-1-induced immune dysfunction on early SARS-CoV-2 clearance.
Errataetall: |
CommentIn: Clin Infect Dis. 2021 Jan 23;72(1):180-182. - PMID 32502247 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
---|---|
Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 71(2020), 16 vom: 19. Nov., Seite 2233-2235 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhao, Juanjuan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibodies, Viral |
---|
Anmerkungen: |
Date Completed 04.12.2020 Date Revised 26.01.2021 published: Print CommentIn: Clin Infect Dis. 2021 Jan 23;72(1):180-182. - PMID 32502247 Citation Status MEDLINE |
---|
doi: |
10.1093/cid/ciaa408 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM308553675 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM308553675 | ||
003 | DE-627 | ||
005 | 20231225131956.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/cid/ciaa408 |2 doi | |
028 | 5 | 2 | |a pubmed24n1028.xml |
035 | |a (DE-627)NLM308553675 | ||
035 | |a (NLM)32270178 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhao, Juanjuan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.12.2020 | ||
500 | |a Date Revised 26.01.2021 | ||
500 | |a published: Print | ||
500 | |a CommentIn: Clin Infect Dis. 2021 Jan 23;72(1):180-182. - PMID 32502247 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
520 | |a The effect of host immune status on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains unknown. Here, we report the first case of coronavirus disease 2019 (COVID-19) with human immunodeficiency virus type 1 (HIV-1)/hepatitis C virus coinfection, who showed a persistently negative SARS-CoV-2 RNA test but delayed antibody response in the plasma. This case highlights the influence of HIV-1-induced immune dysfunction on early SARS-CoV-2 clearance | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a HCV | |
650 | 4 | |a HIV-1 | |
650 | 4 | |a antibody | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
700 | 1 | |a Liao, Xuejiao |e verfasserin |4 aut | |
700 | 1 | |a Wang, Haiyan |e verfasserin |4 aut | |
700 | 1 | |a Wei, Lanlan |e verfasserin |4 aut | |
700 | 1 | |a Xing, Mingzhao |e verfasserin |4 aut | |
700 | 1 | |a Liu, Lei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Zheng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 71(2020), 16 vom: 19. Nov., Seite 2233-2235 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
773 | 1 | 8 | |g volume:71 |g year:2020 |g number:16 |g day:19 |g month:11 |g pages:2233-2235 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa408 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 71 |j 2020 |e 16 |b 19 |c 11 |h 2233-2235 |